ZANVASTRO

This brand name is authorized in United States.

Active ingredients

The drug ZANVASTRO contains one active pharmaceutical ingredient (API):

`1`	Zilganersen UNII `AXQ9493NT2` - ZILGANERSEN
	Zilganersen is an antisense oligonucleotide that causes degradation of glial fibrillary acidic protein (GFAP) pre-mRNA through binding to GFAP pre-mRNA, which results in a reduction of GFAP protein synthesis.
	Read more about Zilganersen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZANVASTRO Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	71860-304

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.